Intestinal Neuroendocrine Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-08
Clinical Trial Update: Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas [Phase 2]
A Phase 2 trial comparing cisplatin/etoposide to temozolomide/capecitabine in patients with advanced poorly differentiated gastrointestinal …